1. Home
  2. NAII vs EGF Comparison

NAII vs EGF Comparison

Compare NAII & EGF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAII
  • EGF
  • Stock Information
  • Founded
  • NAII 1980
  • EGF 2006
  • Country
  • NAII United States
  • EGF United States
  • Employees
  • NAII N/A
  • EGF N/A
  • Industry
  • NAII Medicinal Chemicals and Botanical Products
  • EGF Trusts Except Educational Religious and Charitable
  • Sector
  • NAII Health Care
  • EGF Finance
  • Exchange
  • NAII Nasdaq
  • EGF Nasdaq
  • Market Cap
  • NAII 28.0M
  • EGF N/A
  • IPO Year
  • NAII 1987
  • EGF N/A
  • Fundamental
  • Price
  • NAII $4.42
  • EGF $9.98
  • Analyst Decision
  • NAII
  • EGF
  • Analyst Count
  • NAII 0
  • EGF 0
  • Target Price
  • NAII N/A
  • EGF N/A
  • AVG Volume (30 Days)
  • NAII 18.2K
  • EGF 9.7K
  • Earning Date
  • NAII 11-07-2024
  • EGF 01-01-0001
  • Dividend Yield
  • NAII N/A
  • EGF 5.17%
  • EPS Growth
  • NAII N/A
  • EGF N/A
  • EPS
  • NAII N/A
  • EGF N/A
  • Revenue
  • NAII $113,796,000.00
  • EGF N/A
  • Revenue This Year
  • NAII N/A
  • EGF N/A
  • Revenue Next Year
  • NAII N/A
  • EGF N/A
  • P/E Ratio
  • NAII N/A
  • EGF N/A
  • Revenue Growth
  • NAII N/A
  • EGF N/A
  • 52 Week Low
  • NAII $4.13
  • EGF $9.02
  • 52 Week High
  • NAII $7.37
  • EGF $10.47
  • Technical
  • Relative Strength Index (RSI)
  • NAII 35.54
  • EGF 51.10
  • Support Level
  • NAII $4.22
  • EGF $9.70
  • Resistance Level
  • NAII $4.62
  • EGF $9.99
  • Average True Range (ATR)
  • NAII 0.30
  • EGF 0.07
  • MACD
  • NAII -0.02
  • EGF -0.01
  • Stochastic Oscillator
  • NAII 30.23
  • EGF 70.00

About NAII Natural Alternatives International Inc.

Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

Share on Social Networks: